Nuvilex - 53 Year Dividend History | PMCB
Historical dividend payout and yield for Nuvilex (PMCB) since 1971. The current TTM dividend payout for Nuvilex (PMCB) as of November 20, 2024 is $0.00. The current dividend yield for Nuvilex as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.013B |
$0.000B |
|
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
